Advertisement

Purification and Labeling Strategies for 68Ga from 68Ge/68Ga Generator Eluate

  • Dirk Mueller
  • Ingo Klette
  • Richard P. Baum
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 194)

Abstract

For successful labeling, 68Ge/68Ga generator eluate has to be concentrated (from 10 mL or more to less than 1 mL) and to be purified of metallic impurities, especially Fe(III), and 68Ge breakthrough. Anionic, cationic and fractional elution methods are well known. We describe two new methods: (1) a combined cationic–anionic purification and (2) an easy-to-use and reliable cationic purification with NaCl solution. Using the first method, 68Ga from 10 mL generator eluate was collected on a SCX cartridge, then eluted with 1.0 mL 5.5 M HCl directly on an anion exchanger (30 mg AG1X8). After drying with a stream of helium, 68Ga was eluted with 0.4 mL water into the reaction vial. We provide as an example labeling of BPAMD. Using the second method, 68Ga from 10 mL generator eluate was collected on a SCX cartridge, then eluted with a hydrochloric solution of sodium chloride (0.5 mL 5 M NaCl, 12.5 μL 5.5 M HCl) into the reaction vial, containing 40 μg DOTATOC and 0.5 mL 1 M ammonium acetate buffer pH 4.5. After heating for 7 min at 90°C, the reaction was finished. Radiochemical purity was higher than 95% without further purification. No 68Ge breakthrough was found in the final product.

Keywords

Radiochemical Purity Radiochemical Yield Reaction Vial Ammonium Acetate Solution Mesityl Oxide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Baum RP, Prasad V, Müller D, Schuchardt C, Orlova A, Wennborg A, Tolmachev V, Feldwisch J (2010) Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68 Ga-labeled affibody molecules. J Nucl Med 51:892–897PubMedCrossRefGoogle Scholar
  2. Breeman WA, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP (2005) Radiolabeling DOTA-peptides with 68 Ga. Eur J Nucl Med Mol Imaging 32:478–485PubMedCrossRefGoogle Scholar
  3. de Blois E, Sze Chan H, Naidoo C, Prince D, Krenning EP, Breeman WA (2011) Characteristics of SnO2 based 68Ge/68Ga generator and aspects of radiolabeling DOTA-peptides. Appl Radiat Isot 69:308–315PubMedCrossRefGoogle Scholar
  4. Fellner M, Baum RP, Kubcek V, Hermann P, Lukes I, Prasad VFR (2010) PET/CT imaging of osteoblastic bone metastases with 68 Ga-bisphosphonates: first human study. Eur J Nucl Med Mol Imaging 37:834PubMedCrossRefGoogle Scholar
  5. Hnatowich DJ (1975) A method for the preparation and quality control of 68Ga radiopharmaceuticals. J Nucl Med 16:764PubMedGoogle Scholar
  6. Meyer GJ, Mäcke H, Schuhmacher J, Knapp WH, Hofmann M (2004) 68 Ga-labelled DOTA- derivatised peptide ligands. Eur J Nucl Med Mol Imaging 31:1097–1104PubMedCrossRefGoogle Scholar
  7. Mueller D, Klette I, Wortmann R, Baum RP (2006) Markierung von DOTA-peptiden mit gallium- 68 für die nuklearmedizinische Routinediagnostik. Nuklearmedizin 45:A88–A89Google Scholar
  8. Mueller D, Klette I, Gottschaldt M, Baum RP (2009) Radiolabeling of fragile macroligands with 68Ga. J Labelled Compd Radiopharm 52:477Google Scholar
  9. Prasad V, Baum RP (2010) Biodistribution of the Ga-68 labeled somatostatin analogue DOTA- NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. Q J Nucl Med Mol Imaging 54:61–67PubMedGoogle Scholar
  10. Rösch F (2011) 68Ge/68Ga- generators—past, present and future. World J Nucl Med 10:26Google Scholar
  11. Sainz-Esteban A, Prasad V, Baum RP (2010) Interesting image. Pancreatic neuroendocrine tumor with involvement of the inferior mesenteric vein diagnosed by Ga-68 DOTA-TATE PET/CT. Clin Nucl Med 35:40–41PubMedCrossRefGoogle Scholar
  12. Tolmachev V, Altai M, Sandström M, Perols A, Eriksson Karlström AH, Boschetti F, Orlova A (2011) Evaluation of a maleimido derivative of NOTA for site-specific labeling of affibody molecules. Bioconjug Chem 22:894–902PubMedCrossRefGoogle Scholar
  13. Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rösch F (2007) Processing of generator produced 68 Ga for medical application. J Nucl Med 48:1741–1748PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Department of Nuclear MedicineCentre for PETCT, Zentralklinik Bad BerkaBad BerkaGermany

Personalised recommendations